In June 2016 the United States Anti-Doping Agency (USADA) reported an anti-doping rule violation against the weightlifter Mary C. Hall after her sample tested positive for the prohibited substance oxandrolone.
After notification a provisional suspension was ordered. The Athlete indicated that she wanted a hearing but hereafter duly notified she failed to attend the scheduled hearings of the Tribunal nor did she provide the requested information.
Based on the evidence filed by USADA and without the Athlete’s response the Sole Arbitrator finds that the Athlete’s sample establish the presence of a prohibited substance as anti-doping rule violation committed by the Athlete.
Therefore the AAA Tribunal decides on 24 March 2017:
1.) That Ms. Hall serve a four (4) year period of ineligibility as described in Article 10.2 of the IWF Anti-Doping Policy and the Code, beginning on June 1, 2016, the day Ms. Hall received notice of her provisional suspension;
2.) That Ms. Hall's competitive results obtained on and subsequent to May 6, 2016, the date Ms. Hall participated in the USAW National Championships, be disqualified and that she forfeit any medals, points and prizes obtained on and subsequent to May 6, 2016 consistent with the IWF Anti-Doping Policy;
3.) That Ms. Hall serve a four (4) year period of ineligibility, beginning on June 1, 2016, the day Ms. Hall received notice of her provisional suspension, from participating or coaching in U.S. Olympic, Pan American Games or Paralympic Games Trials, being a member of any U.S. Olympic, Pan American Games or Paralympic Team and having access to the training facilities of the USOC Training Centers or other programs and activities of the USOC including, but not limited to benefits, grants, awards or employment as set forth in Section 6 of the USOC NADP and further defined by Attachment A therein; and,
4.) That Ms. Hall be required to pay any fines, costs, return of prize money, or other financial consequences that may be required by the IWF rules for the violation of its Anti-Doping Policy.
